Tech-PN for Pelvic Inflammatory Disease

Recruiting in Palo Alto (17 mi)

Overseen byMaria Trent, MD, MPH

Age: < 65

Sex: Female

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Johns Hopkins University

No Placebo Group

Trial Summary

What is the purpose of this trial?

The investigators are enrolling 150 young women 13-25 years old diagnosed with pelvic inflammatory disease (PID) in Baltimore to receive community health nurse (CHN) clinical support visits and short messaging system communication support for 30 days. The investigators' intervention group(TECH-PN) will receive additional testing and treatment in the field. The investigators hypothesize that repackaging the recommended Centers for Disease Control and Prevention (CDC) follow-up visit using a technology-enhanced community health nursing intervention (TECH-N) with integration of an evidence-based sexually transmitted infection (STI) prevention curriculum will reduce rates of short-term repeat infection by improving adherence to PID treatment and reducing unprotected intercourse and be more cost-effective compared with outpatient standard of care (and hospitalization).

Research Team

Maria Trent, MD, MPH

Principal Investigator

Johns Hopkins University

Eligibility Criteria

This trial is for young women aged 13-25 in the Baltimore area who have been diagnosed with mild to moderate pelvic inflammatory disease (PID) and are not pregnant. Participants must be willing to sign informed consent, agree to randomization, and be able to communicate and complete study procedures.

Inclusion Criteria

Permanently reside in the Baltimore Metropolitan area

Willing to sign informed consent & be randomized

My pelvic inflammatory disease is not severe.

See 1 more

Exclusion Criteria

I cannot communicate or follow study procedures.

You have experienced sexual assault at the same time as the clinical trial.

You are pregnant.

Treatment Details

Interventions

Tech-PN (Behavioral Intervention)

Trial OverviewThe trial is testing a new approach called TECH-PN which includes community health nurse visits and text message support for 30 days, plus additional field testing and treatment. It aims to improve adherence to PID treatment, reduce unprotected sex, prevent repeat STI infections, and evaluate cost-effectiveness against standard care.

Participant Groups

2Treatment groups

Experimental Treatment

Active Control

Group I: TECH-PNExperimental Treatment1 Intervention

Participants receive community health nurse visits, text-messaging support, additional testing and field based visits with a nurse practitioner.

Group II: TECH-NActive Control1 Intervention

Participants receive enhanced standard of care with community health nurse visits and text-messaging support.